Class 2 recall- All Pholcodine containing products

Reason: Following the conclusion of a review of post-marketing safety data by the MHRA, all pholcodine-containing medicines are being recalled and withdrawn from the UK as a precaution.

MHRA drug alert date: 14/03/23

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-various-marketing-authorisation-holders-pholcodine-containing-products-el-23-a-slash-09?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=61c43c8f-6aa7-4d2a-a81b-73bece5741ba&utm_content=immediately#brief-description-of-the-problem

MHRA ref: MDR 008-12/22

Further Information

For more information or, medical enquiries, please contact the respective companies below:

The Boots Company PLC

Boots Customer Care:

Telephone: 0345 0708090

Thornton & Ross Limited / LCM Limited

Telephone: 01484 848164

Email: thorntonross@medinfomation.co.uk

Bell Sons & Company (Druggists) Limited

Qualified Person for Pharmacovigilance (QPPV): Mr Trevor Price:

Telephone: 0151 422 1216 / mobile: 07739 327 095

Email: trevor.price@bells-healthcare.com

Pinewood Laboratories Limited

Drug Safety & Information department, Wockhardt UK Limited:

Email: drug.safety@wockhardt.co.uk

Telephone: 01978 661261

Glaxosmithkline Consumer Healthcare (UK) Trading Limited

Contact Haleon consumer services:

Telephone: 0800 783 8881

Email: mystory.gb@haleon.com.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.